Relevant publications from our scientists

  • Danger R, Chesneau M,  Paul C,  Guérif P, Durand M, Newell K A, Kanaparthi S, Turka L A, Soulillou J-P, Houlgatte R, Giral M, Ramstein G, and Brouard S. ‘A composite score associated with spontaneous operational tolerance in kidney transplant recipients’. Kidney International 2017: 91(6): 1473–1481.
  • Danger R, Sawitzki B, and Brouard S. ‘Immune monitoring in renal transplantation: The search for biomarkers’. Eur. J. Immunol 2016: 46: 2695–2704.
  • Chesneau M, Miche L, Dugast E, Chenouard A, Baron D, Pallier A, Durand J, Braza F, Guerif P, Laplaud D-A, Soulillou J-P, Magali Giral M, Nicolas Degauque N, Elise Chiffoleau E, and Brouard S. ‘Tolerant Kidney Transplant Patients Produce B Cells with Regulatory Properties ‘. J Am Soc Nephrol 2015: 26: 2588–2598.
  • Baron D, Ramstein G, Chesneau M, Echasseriau Y, Pallier A, Paul C, Degauque N, Hernandez-Fuentes MP, Sanchez-Fueyo A, Newell KA, Giral M, Soulillou J-P, Houlgatte R, and Brouard S. ‘A common gene signature across multiple studies relate biomarkers and functional regulation in tolerance to renal allograft’. Kidney International 2015: 87, 984–995.
  • Chesneau M, Pallier A, Braza F, Lacombe G, Le Gallou S,  Baron D, Giral M, Danger R, Guerif P, Aubert-Wastiaux H, Néel A, Michel L, Laplaud D-A, Degauque N, Soulillou J-P, Tarte K, and Brouard S. ‘Unique B Cell Differentiation Profile in Tolerant Kidney Transplant Patients’.  Am J Transplant 2013: 14: 144–155.
  • Pallier A, Hillion S, Danger R, Magali Giral M, Racape M, Degauque N, Dugast E, Ashton-Chess J, Pettre S, Lozano JJ, Bataille R, Devys A, Cesbron-Gautier A, Braudeau C, Larrose C, Soulillou J-Pand Brouard S. ‘Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype ‘. Kidney International 2010: 78, 503–513.
  • Brouard S, Mansfield E, Braud C, Li L, Giral M,  Hsieh S-C, Baeten D, Zhang M, Ashton-Chess J, Braudeau C, Hsieh F, Dupont A, Pallier A, Moreau A, Louis S , Ruizh C, Salvatierra O, Soulillou J-P, and Sarwal M. ‘Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance’. PNAS 2007: vol. 104, no. 39, 15448–15453.

Other publications of interest

  • Puttarajappa C.M, Mehta R.B, Roberts M.S, Smith K.J, Hariharan S. ‘Economic analysis of screening for subclinical rejection in kidney transplantation using protocol biopsies and noninvasive biomarkers’. Am J Transplant 2021: 21:186–197.
  • Thaunat O. ‘Finding the safe place between the hammer and the anvil: sounding the depth of therapeutic immunosuppression’. Kidney International 2015: 88, 1226–1228.
  • Lamb K.E, Lodhi S and Meier-Kriesche H.-U. ‘Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal’. Am J Transplant 2011: 11: 450–462.
  • Nankivell B.J, Borrows R.J, Fung C.L.-S, O’Connell P.J, Allen R.D.M, and Chapman J.R. ‘Natural History, Risk Factors, and Impact of Subclinical Rejection in Kidney Transplantation’. Transplantation 2004: 78: 242–249.
  • Miller L.W. ‘Cardiovalscular toxicities of immunosupressive agents’. Am J Transplant 2002: 2: 807-818.
  • Furness P.N, Taub N. ‘International variation in the interpretation of renal transplant biopsies: report of the CERTPAP Project’. Kidney International 2001: 60:1998–2012.